Max Flogegård
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Lymphoma Diagnosis and Treatment 5
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 1
- Co-authors
- Gunilla Enblad (4 shared papers)Antonios Valachis (2 shared papers)Hareth Nahi (4 shared papers)Olle Linder (1 shared paper)Per‐Ola Andersson (1 shared paper)Erik Holmberg (1 shared paper)Björn Andréasson (1 shared paper)Peter Gimsing (1 shared paper)
In The Last Decade
Max Flogegård
8 papers receiving 114 citations
Peers
Comparison fields: 5 of 36
- Hematology 48
- Oncology 41
- Pathology and Forensic Medicine 26
- Genetics 8
- Family Practice 1
Countries citing papers authored by Max Flogegård
This map shows the geographic impact of Max Flogegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Flogegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Flogegård more than expected).
Fields of papers citing papers by Max Flogegård
This network shows the impact of papers produced by Max Flogegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Flogegård. The network helps show where Max Flogegård may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Flogegård, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 41 | |
| 2 | 2019 | 22 | |
| 3 | 2021 | 15 | |
| 4 | 2019 | 15 | |
| 5 | 2018 | 13 | |
| 6 | 2015 | 9 | |
| 7 | 2012 | 1 | |
| 8 | 2025 | 1 | |
| 9 | 2024 | 0 |
About Max Flogegård
Max Flogegård is a scholar working on Pathology and Forensic Medicine, Hematology, Molecular Biology, Oncology and Genetics, having authored 9 papers that have together received 117 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Acute Myeloid Leukemia Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Hematology (48 citations), Oncology (41 citations), Pathology and Forensic Medicine (26 citations), Genetics (8 citations) and Family Practice (1 citation). Max Flogegård has collaborated with scholars based in Sweden, Norway and Denmark. Frequent co-authors include Gunilla Enblad, Antonios Valachis, Hareth Nahi, Olle Linder, Per‐Ola Andersson, Erik Holmberg, Björn Andréasson, Peter Gimsing, Margaretha S. Carlsson and Øyvind Hjertner. Their work appears in journals such as British Journal of Haematology, Acta Oncologica, Blood, Genes Chromosomes and Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.